BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37763347)

  • 1. Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Parameters Could Predict International Society of Urological Pathology Risk Groups of Prostate Cancers on Radical Prostatectomy.
    Chang CB; Lin YC; Wong YC; Lin SN; Lin CY; Lin YH; Sheng TW; Yang LY; Wang LJ
    Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2.
    Afshari Mirak S; Mohammadian Bajgiran A; Sung K; Asvadi NH; Markovic D; Felker ER; Lu D; Sisk A; Reiter RE; Raman SS
    Abdom Radiol (NY); 2020 Jul; 45(7):2225-2234. PubMed ID: 31549211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Biological Feature and Its Association with Positive Surgical Margins and Apical Margins after Radical Prostatectomy in Non-Metastasis Prostate Cancer.
    Wang S; Du P; Cao Y; Yang X; Yang Y
    Curr Oncol; 2021 Apr; 28(2):1528-1536. PubMed ID: 33924669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies.
    Ferro M; Terracciano D; Musi G; de Cobelli O; Vartolomei MD; Damiano R; Cantiello F; Buonerba C; Morelli M; Mistretta FA; Luzzago S; Perdonà S; Del Prete P; Del Giudice F; Busetto GM; Porreca A; Autorino R; Manfredi M; Porpiglia F; Muto M; Loizzo D; Ditonno P; Battaglia M; Lucarelli G
    Urol Int; 2022; 106(1):75-82. PubMed ID: 34167120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant reduction in positive surgical margin rate after laparoscopic radical prostatectomy by application of the modified surgical margin recommendations of the 2009 International Society of Urological Pathology consensus.
    Maxeiner A; Magheli A; Jöhrens K; Kilic E; Braun TL; Kempkensteffen C; Hinz S; Stephan C; Miller K; Busch J
    BJU Int; 2016 Nov; 118(5):750-757. PubMed ID: 26915345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation analysis between prostate imaging report and data system score and pathological results of prostate cancer].
    Zhu LY; Ding XF; Huang TB; Luan Y; Guo CH; Xu YZ; Wang F
    Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(34):2663-2668. PubMed ID: 32921014
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T.
    Vos EK; Litjens GJ; Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Huisman HJ; Scheenen TW
    Eur Urol; 2013 Sep; 64(3):448-55. PubMed ID: 23751135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IVIM Parameters on MRI Could Predict ISUP Risk Groups of Prostate Cancers on Radical Prostatectomy.
    Chang CB; Lin YC; Wong YC; Lin SN; Lin CY; Lin YH; Sheng TW; Huang CC; Yang LY; Wang LJ
    Front Oncol; 2021; 11():659014. PubMed ID: 34277409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic modeling of dynamic contrast-enhanced (DCE)-MRI in PI-RADS category 3 peripheral zone lesions: preliminary study evaluating DCE-MRI as an imaging biomarker for detection of clinically significant prostate cancers.
    Abreu-Gomez J; Lim C; Cron GO; Krishna S; Sadoughi N; Schieda N
    Abdom Radiol (NY); 2021 Sep; 46(9):4370-4380. PubMed ID: 33818626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative parameters in dynamic contrast-enhanced magnetic resonance imaging for the detection and characterization of prostate cancer.
    Wei C; Jin B; Szewczyk-Bieda M; Gandy S; Lang S; Zhang Y; Huang Z; Nabi G
    Oncotarget; 2018 Mar; 9(22):15997-16007. PubMed ID: 29662622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
    Kang SR; Kim HW; Kim HS
    J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
    Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
    BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retzius-sparing Robot-assisted Radical Prostatectomy in High-risk Prostate Cancer Patients: Results from a Large Single-institution Series.
    Dell'Oglio P; Tappero S; Longoni M; Buratto C; Scilipoti P; Secco S; Olivero A; Barbieri M; Palagonia E; Napoli G; Strada E; Petralia G; Di Trapani D; Vanzulli A; Bocciardi AM; Galfano A
    Eur Urol Open Sci; 2022 Apr; 38():69-78. PubMed ID: 35265866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgeon volume and body mass index influence positive surgical margin risk after robot-assisted radical prostatectomy: Results in 732 cases.
    Porcaro AB; Tafuri A; Sebben M; Corsi P; Processali T; Pirozzi M; Amigoni N; Rizzetto R; Shakir A; Cacciamani G; Mariotto A; Brunelli M; Bernasconi R; Novella G; De Marco V; Artibani W
    Arab J Urol; 2019; 17(3):234-242. PubMed ID: 31489241
    [No Abstract]   [Full Text] [Related]  

  • 15. [Establishment and evaluation of a model for predicting ISUP pathological grade≥2 before radical prostatectomy].
    Wang YF; Zhang YY; Tan SX; Pan P; Wei CG; Shen JK
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(45):3754-3759. PubMed ID: 34856705
    [No Abstract]   [Full Text] [Related]  

  • 16. Preoperative MRI-based estimation of risk for positive resection margin after radical prostatectomy in patients with prostate cancer: development and validation of a simple scoring system.
    Park MY; Park KJ; Kim MH; Kim JK
    Eur Radiol; 2021 Jul; 31(7):4898-4907. PubMed ID: 33386982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.
    Lebdai S; Mathieu R; Leger J; Haillot O; Vincendeau S; Rioux-Leclercq N; Fournier G; Perrouin-Verbe MA; Doucet L; Azzouzi AR; Rigaud J; Renaudin K; Charles T; Bruyere F; Fromont G
    Urol Oncol; 2018 Feb; 36(2):80.e17-80.e24. PubMed ID: 29153942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Dispersion MRI for Improved Prostate Cancer Diagnosis in a Multicenter Study.
    Turco S; Lavini C; Heijmink S; Barentsz J; Wijkstra H; Mischi M
    AJR Am J Roentgenol; 2018 Nov; 211(5):W242-W251. PubMed ID: 30346837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal nodular enhancement on DCE MRI of the prostatectomy bed: radiologic-pathologic correlations and prognostic value.
    Park MY; Park KJ; Kim MH; Kim JK
    Eur Radiol; 2023 Apr; 33(4):2985-2994. PubMed ID: 36350389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft tissue sarcoma: can dynamic contrast-enhanced (DCE) MRI be used to predict the histological grade?
    Li X; Wang Q; Dou Y; Zhang Y; Tao J; Yang L; Wang S
    Skeletal Radiol; 2020 Nov; 49(11):1829-1838. PubMed ID: 32519183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.